A clinical study of MK-0472 in people with solid tumors (MK-0472-001)
MK-0472-001
Phase 1 other active
Quick answer
A clinical study of MK-0472 in people with solid tumors (MK-0472-001) for Malignant Neoplasm - Solid Tumors is a Phase 1 program (other) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Malignant Neoplasm - Solid Tumors
- Phase
- Phase 1
- Modality
- other
- Status
- active